Many studies reported CADM1 as a tumor suppressor in several cancer types, including ovarian, breast, and pancreatic cancers, and the loss of CADM1 expression is closely associated with cancer progression and metastasis [28,29,30]. This evidence concerns the gene CADM1 and familial pancreatic carcinoma.